Sourcing without documentation is not research
In cardiomyocytes, GLP-1R activation has no significant effect on myocardial glucose metabolism under nonischemic conditions [23], but there is an increased expression of oxidative phosphorylation protein and a simultaneous downregulation of glycolysis pathways during the early phases of myocardial infarction [24]
In OECD countries, 74.1% of GLP-1 nutritional products are dispensed via prescription
This framework is evidence-informed rather than a validated GLP-1specific guideline
Individual circumstances: While guidelines are in place, a doctor is ultimately responsible for making decisions appropriate for each patient
Consult with your healthcare provider, and they may adjust, switch, or stop the medication